TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Mangoceuticals, Inc. ( (MGRX) ) just unveiled an update.
On September 9, 2025, Mangoceuticals, Inc. granted shares and options to key executives and board members as part of their 2022 Equity Plan. CEO Jacob D. Cohen received 500,000 shares and options to purchase 2,000,000 shares, while other executives and board members received 100,000 shares each. The options have a ten-year term and specific vesting conditions, reflecting the company’s strategy to incentivize leadership and align their interests with company performance.
More about Mangoceuticals, Inc.
Average Trading Volume: 158,356
Technical Sentiment Signal: Hold
Current Market Cap: $22.44M
For detailed information about MGRX stock, go to TipRanks’ Stock Analysis page.